| Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme R Pallini, L Ricci-Vitiani, GL Banna, M Signore, D Lombardi, M Todaro, ... Clinical Cancer Research 14 (24), 8205-8212, 2008 | 425 | 2008 |
| Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma V Spina, A Bruscaggin, A Cuccaro, M Martini, M Di Trani, G Forestieri, ... Blood, The Journal of the American Society of Hematology 131 (22), 2413-2425, 2018 | 304 | 2018 |
| Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome D Rossi, V Spina, M Cerri, S Rasi, C Deambrogi, L De Paoli, L Laurenti, ... Clinical Cancer Research 15 (13), 4415-4422, 2009 | 262 | 2009 |
| Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis M Buccarelli, M Marconi, S Pacioni, I De Pascalis, QG D’Alessandris, ... Cell death & disease 9 (8), 841, 2018 | 222 | 2018 |
| Ultrasound molecular imaging with BR55 in patients with breast and ovarian lesions: first-in-human results JK Willmann, L Bonomo, AC Testa, P Rinaldi, G Rindi, KS Valluru, ... Journal of Clinical Oncology 35 (19), 2133-2140, 2017 | 221 | 2017 |
| Possible involvement of hMLH1, p16INK4a and PTEN in the malignant transformation of endometriosis M Martini, M Ciccarone, G Garganese, C Maggiore, A Evangelista, ... International Journal of Cancer 102 (4), 398-406, 2002 | 197 | 2002 |
| Expression of EGFRvIII in glioblastoma: prognostic significance revisited N Montano, T Cenci, M Martini, QG D’Alessandris, F Pelacchi, ... Neoplasia 13 (12), 1113-IN6, 2011 | 177 | 2011 |
| Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas S Hohaus, M Giachelia, G Massini, G Mansueto, B Vannata, V Bozzoli, ... Annals of oncology 20 (8), 1408-1413, 2009 | 177 | 2009 |
| Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis R Pallini, L Ricci‐Vitiani, N Montano, C Mollinari, M Biffoni, T Cenci, ... Cancer 117 (1), 162-174, 2011 | 140 | 2011 |
| Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome. D Rossi, S Rasi, V Spina, M Fangazio, S Monti, M Greco, C Ciardullo, ... British journal of haematology 158 (3), 2012 | 134 | 2012 |
| The viral load of Epstein–Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma S Hohaus, R Santangelo, M Giachelia, B Vannata, G Massini, A Cuccaro, ... Clinical Cancer Research 17 (9), 2885-2892, 2011 | 130 | 2011 |
| Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin’s lymphomas A Cingolani, R Gastaldi, L Fassone, F Pierconti, ML Giancola, M Martini, ... Journal of Clinical Oncology 18 (19), 3325-3330, 2000 | 128 | 2000 |
| Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia L Teofili, F Giona, M Martini, T Cenci, F Guidi, L Torti, G Palumbo, ... Journal of clinical oncology 25 (9), 1048-1053, 2007 | 124 | 2007 |
| MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia L De Paoli, M Cerri, S Monti, S Rasi, V Spina, A Bruscaggin, M Greco, ... Leukemia & lymphoma 54 (5), 1087-1090, 2013 | 122 | 2013 |
| Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome F Giona, L Teofili, ML Moleti, M Martini, G Palumbo, A Amendola, ... Blood, The Journal of the American Society of Hematology 119 (10), 2219-2227, 2012 | 112 | 2012 |
| Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? A Inno, M Di Salvatore, T Cenci, M Martini, A Orlandi, A Strippoli, ... Clinical colorectal cancer 10 (4), 325-332, 2011 | 111 | 2011 |
| BRAF (V600E) mutation analysis on liquid‐based cytology‐processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid … ED Rossi, M Martini, S Capodimonti, CP Lombardi, A Pontecorvi, ... Cancer cytopathology 121 (6), 291-297, 2013 | 106 | 2013 |
| Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior F Pierconti, M Martini, F Pinto, T Cenci, S Capodimonti, A Calarco, ... The Prostate 71 (3), 318-325, 2011 | 106 | 2011 |
| Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis L Teofili, F Giona, L Torti, T Cenci, BM Ricerca, C Rumi, V Nunes, R Foà, ... haematologica 95 (1), 65, 2009 | 106 | 2009 |
| Metabolic/proteomic signature defines two glioblastoma subtypes with different clinical outcome G Marziali, M Signore, M Buccarelli, S Grande, A Palma, M Biffoni, A Rosi, ... Scientific reports 6 (1), 21557, 2016 | 104 | 2016 |
